FDA 483 - American Preclinical Services - May 04, 2011

An FDA inspection of American Preclinical Services in Minneapolis, MN, a nonclinical laboratory, revealed significant deficiencies. Observations included the use of expired test articles, a lack of established procedures for documenting the receipt and distribution of test and control articles, and failures in periodically analyzing animal water for contaminants.